Vitamin D Shows Potential in Managing Metabolic Health for Diabetes

Recent findings from a 12-week prospective study have illuminated the potential of high-dose vitamin D3 as a strategic tool for managing metabolic health in patients with type 2 diabetes (T2D). The research, published in Frontiers in Endocrinology, followed 200 participants with obesity who were already maintaining stable metformin therapy.¹

Vitamin D is a fat-soluble vitamin that may help prevent and treat autoimmune diseases, including diabetes. In a literature review published in Cureus, investigators found significant associations with type 1 diabetes (T1D) and T2D development and reductions in glycated hemoglobin for patients with T1D.²

“High-dose VDS was associated with improved vitamin D status and modest improvements in glycemic control in obese patients with T2D,” the study authors said.¹ “These findings should be interpreted as associative rather than causal and support further investigation in randomized, placebo-controlled trials with extended follow-up and mechanistic end points.”

Results of the Study

The study was a 12-week prospective cohort study conducted in Poland from October 1, 2024, to March 31, 2025. Patients were recruited from a single outpatient metabolic clinic.¹

“In this 12-week prospective ambulatory cohort of patients with T2D, high-dose VDS [vitamin D supplementation] was associated with a marked rise in serum 25(OH)D concentrations and modest but statistically significant improvements in glycemic control (FSG [fasting serum glucose] and HbA1c), without significant effects on SBP [systolic blood pressure], DBP [diastolic blood pressure], serum calcium, or BMI [body mass index],” the study authors said.¹

By administering a daily dose of 4000 IU, researchers observed that participants successfully moved from a state of deficiency to sufficiency, with mean serum levels rising from approximately 21 ng/mL to 45 ng/mL. This correction of vitamin D status was linked to statistically significant reductions in fasting serum glucose and glycated hemoglobin (HbA1c), suggesting that the supplement acts as a valuable adjunct to traditional medication.¹

The biological rationale for these improvements lies in the nutrient’s role in regulating insulin secretion and modulating inflammation within the body. Vitamin D is believed to enhance insulin sensitivity by modulating intracellular calcium levels in pancreatic beta-cells and hepatocytes.¹

However, the study also highlighted the unique hurdles faced by patients with obesity, noting that high-dose regimens are often necessary because vitamin D can become sequestered in adipose tissue, which reduces its overall bioavailability. Although the metabolic markers showed promise, the 12-week intervention did not produce significant changes in BMI or blood pressure, indicating that vitamin D is one part of the solution rather than a standalone answer for weight loss.¹

The Role of the Pharmacist in Supplement Safety

As the global market for dietary supplements grows, the pharmacist’s position as a frontline healthcare provider has become increasingly critical for patient safety. In regions like Italy, nearly 95% of these products are sold within pharmacies, and over 80% of citizens rely on their pharmacist or physician for guidance before making a purchase.³

Pharmacists are uniquely positioned to identify and prevent harmful drug-drug interactions, such as those between vitamin K and oral anticoagulants, or to warn against the risks of chronic vitamin A or E toxicity. They also serve as a vital shield against products that may contain unlabeled toxic ingredients or carry unsubstantiated health claims found on social media.³

Despite this responsibility, recent observational data suggests that significant knowledge gaps persist among some pharmacy professionals. A survey in northeastern Italy revealed that only about one-third of pharmacists met a minimum standard of knowledge regarding supplements, with many struggling to identify the recommended daily allowances for essential vitamins.³

Younger professionals, in particular, were found to have lower scores regarding the potential carcinogenicity of multivitamin misuse and the specific nutritional needs of complex patient groups, such as those undergoing chemotherapy. Furthermore, although pharmacists believe the pharmacy is the safest place for these transactions, some face an ethical conflict between profit motives and clinical counseling. Addressing these educational gaps through continuous professional development is essential to ensure that patients with diabetes and obesity receive the tailored, evidence-based guidance they need to use supplements safely and effectively.³

READ MORE: Diabetes Resource Center

Are you ready to elevate your pharmacy practice? Sign up today for our free Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips straight to your inbox.

REFERENCES

1. Hoffmann K, Bryl W, Bhongade B, et al. Vitamin D supplementation and selected metabolic parameters in patients with type 2 diabetes and obesity: a prospective observational study. Front Endocrinol (Lausanne). 2026;16:1750040. Published 2026 Jan 14. doi:10.3389/fendo.2025.1750040

2. Abugoukh TM, Al Sharaby A, Elshaikh AO, et al. Does Vitamin D Have a Role in Diabetes?. Cureus. 2022;14(10):e30432. Published 2022 Oct 18. doi:10.7759/cureus.30432

3. Brunelli L, Arnoldo L, Mazzilis G, et al. The knowledge and attitudes of pharmacists related to the use of dietary supplements: An observational study in northeastern Italy. Prev Med Rep. 2022;30:101986. Published 2022 Sep 19. doi:10.1016/j.pmedr.2022.101986